ClinConnect ClinConnect Logo
Search / Trial NCT06996925

Depression, Illness Perception, and Erectile Dysfunction Outcomes

Launched by HASEKI TRAINING AND RESEARCH HOSPITAL · May 21, 2025

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Erectile Dysfunction Depression Self Perception

ClinConnect Summary

This prospective, observational study aims to investigate the relationship between illness perception and depressive symptoms in patients diagnosed with erectile dysfunction (ED), and how these factors influence treatment response over time. Erectile dysfunction is a multifactorial condition that significantly affects quality of life and can be shaped by psychological and cognitive factors, including patients' perceptions of their disease.

A total of 120 adult male participants (aged \>18 years) diagnosed with ED will be enrolled from multiple urology centers. Patients will complete three ...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male patients aged 18 years or older
  • Diagnosed with erectile dysfunction by a physician
  • Able and willing to provide written informed consent
  • Exclusion Criteria:
  • History of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder)
  • Ongoing or prior hormonal therapy or active cancer treatment
  • Neurological conditions that could impact erectile function

About Haseki Training And Research Hospital

Haseki Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Istanbul, Turkey, the hospital combines extensive clinical expertise with a commitment to excellence in research, providing a collaborative environment for healthcare professionals and researchers. With a focus on a wide range of medical disciplines, Haseki Hospital aims to contribute to the scientific community by facilitating rigorous clinical studies that adhere to the highest ethical standards, ultimately enhancing treatment options and outcomes for patients.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Furkan Gunay, Medical doctor

Principal Investigator

Haseki Education and Research Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported